Roberta Zani
YOU?
Author Swipe
View article: #2266 Integrating palliative care into nephrology: a single-center “action-research” process
#2266 Integrating palliative care into nephrology: a single-center “action-research” process Open
Background and Aims Recognizing the need to integrate palliative care into nephrology, an “action-research” model was launched in April 2023. Method A multidisciplinary pilot group (6 nephrologists, 7 nurses), led by a psychologist, was es…
View article: Sarcopenia and it’s influencing factors among adults with asthma, chronic obstructive pulmonary disease, and tuberculosis in Penang, Malaysia
Sarcopenia and it’s influencing factors among adults with asthma, chronic obstructive pulmonary disease, and tuberculosis in Penang, Malaysia Open
This study highlighted a significant burden of sarcopenia among patients with asthma, COPD and TB. Non-clinical interventions such as lifestyle modification and nutritional support to the patients are crucial to maintain muscle strength an…
View article: Sarcopenia and It's Influencing Factors Among Adults With Asthma, Chronic Obstructive Pulmonary Disease, and Tuberculosis in Penang, Malaysia
Sarcopenia and It's Influencing Factors Among Adults With Asthma, Chronic Obstructive Pulmonary Disease, and Tuberculosis in Penang, Malaysia Open
Background Chronic respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), and tuberculosis (TB) are increasing globally, leading to systemic symptoms like skeletal muscle dysfunction. Ageing and physical inactivity…
View article: Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) Open
View article: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) Open
View article: COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis Open
Vaccination against SARS-CoV-2 has been performed in a high percentage of MCV patients with encouraging safety profile. Vasculitis flares rate was in line with that observed for other autoimmune diseases, despite patients with purpura or p…
View article: SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response Open
View article: THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME Open
View article: Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients Open
View article: Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study Open